Cure8 research brief
The paper identifies Candida albicans–reactive Th17 cells that travel between oral and gut mucosa and become more pathogenic in Crohn’s disease, suggesting a fungal–immune link that could matter for disease mechanisms and future therapies.
Researchers in IBD and mucosal immunology; clinicians following IBD pathogenesis research; informed patients interested in the role of microbes (fungi) in Crohn’s disease.
This Immunity abstract reports that Candida albicans–reactive Th17 cells target a narrow set of fungal proteins and normally reside in the oral mucosa but share T cell clonotypes with gut tissues. In Crohn’s disease patients, these C.
albicans–specific Th17 cells were enriched in inflamed intestinal tissue and showed features of a more pathogenic Th17 program, while keeping focused antigen specificity.
These findings come from immunology and T cell receptor profiling reported in the journal abstract; they identify a specific, antigen-restricted Th17 subset that links oral and gut mucosal immunity and appears to adapt functionally during intestinal inflammation.
Based on the Immunity abstract (not a full article text). Findings are mechanistic/basic-science; do not imply treatment changes. Further work is needed to translate into clinical interventions.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of interests The authors declare no competing interests.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Cure8 found this source from sciencedirect.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original article for...
Fibrosis and stricturing are key problems in Crohn’s disease with limited therapies; this study identifies a microbiota–bile acid–GPBAR1 pathway by which a specific probiotic mix reduced inflammation and fibrosis in...
The study identifies a specific protein interaction that may underlie persistent inflammation; for people with Crohn’s and other inflammatory conditions this points to a potential new, more targeted treatment approach in...
